Patent · US Active

Methods and compositions for vitamin K epoxide reductase

US7858318B2 · kind B2 · utility

7Cited by

13References

15Claims

0Family size

Assignee

The University of North Carolina at Chapel Hill · US

Inventors

Darrel W. Stafford · Carrboro, US
Tao Li · San Diego, US

Key dates

Filing date	Jan 28, 2009
Grant date	Dec 28, 2010
Priority date	—
Expiry date	Jan 28, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/172
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide polymorphism in the VKOR gene, wherein the single nucleotide polymorphism is correlated with increased or decreased sensitivity to warfarin, thereby identifying the subject having increased or decreased sensitivity to warfarin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.